Novo Asks NJ Judge To Stop Lilly's 'Deceptive' GLP-1 Ads
Novo Nordisk Inc. asked a New Jersey federal court Friday to block rival Eli Lilly & Co. from running ads allegedly comparing their respective GLP-1 drugs using "outdated" clinical trials and...To view the full article, register now.
Already a subscriber? Click here to view full article